GRI GRI Bio Corporation Earnings per share growth this year
GRI Bio, Inc. (GRI) focuses on developing NKT therapy against fibrosis, relying on R&D funding, while patent protection shields its innovations from pricing pressure. The year-over-year growth in earnings per share on the GURU.Markets chart reflects a trend where the value of 96.00 represents the latest figure. The company's revenues rely on the supply of high-cost targeted drugs to insurance funds and medical centers.
Financial and market metric breakdowns for GRI Bio, Inc. (GRI)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio GRI Bio, Inc.|GRI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient gribio.com|GRI - Company Total Debt|Debt to Net Assets Ratio GRI Bio Corporation|GRI - Company Long-Term Debts|Company Short-Term Debt GRI Bio|Interim Coverage Ratio gribio.com
- company profitability and valuation multiples indicators:
GRI - Company Net Income|Expected Net Profit GRI Bio, Inc.|GRI - Price to Earnings Ratio|Future Price to Earnings Multiple GRI Bio Corporation|GRI - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRI Bio Corporation|GRI - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months GRI Bio|GRI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months gribio.com|GRI - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year GRI Bio, Inc.
Summary company analysis:GRI Bio Inc (GRI)
This indicator measures the year-over-year growth rate of earnings per share, reflecting the efficiency of business scaling. The formula's dynamics depend critically on quarterly reports, capturing transitions from losses to profitability. By analyzing current year-over-year EPS trends, an investor can identify the risks of the venture model at GRI Bio, Inc. (GRI), where R&D expenditures for NKT therapy dominate profits.
Direct competitors
argenx N.V. (ARGX) - Earnings growth in current year|Earnings per share growth in current year BioNTech Group|Earnings per share growth this year ABVX (abivax.com)|Earnings growth in current year ADMA|PTGX - Earnings per share growth rate in current year|Earnings growth in current year IMVT (Immunovant)|Net earnings per share change in current year Kiniksa Pharmaceuticals, Ltd.|GRFS - Earnings per share growth in current year|Earnings per share increase in current year ADPT (Adaptive Biotechnologies Inc.)|CLDX: Earnings growth in current year|AUPH - Expected net earnings per share growth this year|Net earnings per share growth this year BCRX|VERA: Earnings per share increase in current year|Earnings growth in current year DNTH|Earnings per share growth in current year PHVS (Pharvaris Pharma)|Earnings growth in current year ABCL (AbCellera Biologics)|Expected net earnings per share growth this year tourmalinebio.com (TRML)|PGEN - Earnings per share growth in current year|Earnings per share growth rate in current year Pharming Group NV|NKTR (Nektar) - Net earnings per share growth this year|Upstream Pharma - Earnings per share increase in current year|ZBIO (Zenas Biopharma Inc) - Earnings growth in current year|immunome.com (IMNM) - Expected net earnings per share growth this year|Earnings per share growth in current year Gossamer Bio (GOSS)|KalVista Pharma - Earnings per share growth this year|Earnings growth in current year SEPN (Septerna Corp)|PVLA - Net earnings per share growth this year|SVRA: Net earnings per share growth this year|Expected net earnings per share growth this year rigel.com RIGL|ANAB: Earnings growth in current year|Net earnings per share change in current year Astria Therapeutics Inc ATXS|Earnings per share growth in current year enGene Bio|RAPT: Earnings per share increase in current year|Earnings growth in current year JBIO|Expected net earnings per share growth this year aclaristx.com|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|TLSA (Tiziana Life Sciences Ltd.) - Earnings per share trend in current year|Cabaletta Bio, Inc - Earnings growth in current year|Earnings per share increase in current year VTYX (Ventyx Biosciences, Inc)|THTX: Earnings growth in current year|avalotx.com (AVTX) - Earnings growth in current year|Earnings per share growth in current year Eledon Pharmaceuticals, Inc.|AGEN: Earnings per share increase in current year|Earnings per share growth in current year Climb Bio, Inc. (CLYM)|Net earnings per share growth this year Zura Bio Ltd ZURA|Earnings growth in current year ATYR (aTyr Pharma, Inc.)|Earnings growth in current year Adagene Inc ADAG|IMA: Net earnings per share growth this year|Earnings per share increase in current year STTK (Shattuck Labs, Inc.)|EQ: Earnings growth in current year|CNTB - Expected net earnings per share growth this year|Earnings per share growth in current year Immunic Therapeutics|Net earnings per share growth this year Atara Biotherapeutics Inc (ATRA)|Earnings per share growth in current year InflaRx N.V. (IFRX)|Net earnings per share growth this year X4 Pharmaceuticals Inc. XFOR|Adicet Bio, Inc. - Net earnings per share growth this year|Earnings growth in current year Celularity Inc CELU|INMB - Earnings per share growth in current year|BRNS (barinthusbio.com) - Earnings per share growth this year|KZR: Earnings growth in current year|Earnings per share growth rate in current year SAB Biotherapeutics Inc. (SABS)|AKTX (Akari Therapeutics plc) - Earnings growth in current year|ENLV - Net earnings per share change in current year|Earnings per share growth in current year Q32 Bio Inc. (QTTB)|GOVX (geovax.com) - Earnings per share increase in current year|Earnings growth in current year EDSA (Edesa Biotech)|Expected net earnings per share growth this year iBio Inc (IBIO)|CARM: Net earnings per share growth this year|Earnings per share increase in current year XTLB (XTL Bio)|BOLT: Earnings growth in current year|HCWB (HCW Biologics) - Earnings per share growth in current year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth in current year|AIM ImmunoTech, Inc. (AIM) - Expected net earnings per share growth this year|Earnings per share growth in current year Aditxt (ADTX)|XRTX - Earnings per share growth rate in current year|Vyome Holdings Inc - Net earnings per share growth this year|Earnings per share increase in current year REVB|Indaptus Therapeutics, Inc. - Earnings growth in current year|Expected net earnings per share growth this year Scinai Immunotherapeutics Ltd SCNI|calcimedica.com (CALI) - Earnings per share growth in current year|Earnings per share growth this year AFMD|ALLK (Allakos Inc) - Earnings growth in current year|Net earnings per share growth this year HOOKIPA (HOOK)|Net earnings per share growth this year IGMS (IGM Biosciences, Inc.)|Expected net earnings per share growth this year iTeos Therapeutics Inc|Earnings growth in current year OCEA (Ocean Bio)|Net earnings per share change in current year TC BioPharm Ltd|THRD - Earnings per share growth in current year
